In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin

Clinical Oral Investigations

Volumn 17, Issue 4, 2013, Pages 1273-1278

  Broekema, Ferdinand I ^a   van Oeveren, Wim ^a,b   Selten, Maaike H A ^a   Meijer, Rolf J H ^a   de Wolf, Joost T M ^a   Bos, Rudolf R M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HaemoScan   (Netherlands)

Author keywords

Collagen; Gelatin; Hemostasis; In vivo test; Polyurethane

Indexed keywords

EID: 84876441047     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-012-0809-y     Document Type: Article

References (25)

1. Nemoto T, Horiuchi M, Ishiguro N, Shinagawa M (1999) Detection methods of possible prion contaminants in collagen and gelatin. Arch Virol 144(1): 177-84.
2. Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23(1): 47-55.
3. van Minnen B, van Leeuwen MB, Kors G, Zuidema J, van Kooten TG, Bos RR (2008) In vivo resorption of a biodegradable polyurethane foam, based on 1, 4-butanediisocyanate: a three-year subcutaneous implantation study. J Biomed Mater Res A 85(4): 972-82.
4. Visscher SH, van Minnen B, van Leeuwen MB, van Kooten TG, Bos RR (2009) Closure of oroantral communications using biodegradable polyurethane foam: a long term study in rabbits. J Biomed Mater Res B 91(2): 957-63.
5. Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25(26): 5681-703.
6. Broekema FI, van Oeveren W, Zuidema J, Visscher SH, Bos RR (2011) In vitro analysis of polyurethane foam as a topical hemostatic agent. J Mater Sci Mater Med 22(4): 1081-6.
7. Furie B, Furie BC (2007) In vivo thrombus formation. J Thromb Haemost 1: 12-17.
8. Pelzer H, Schwarz A, Heimburger N (1988) Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59(1): 101-6.
9. Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30(43): 10363-70.
10. Kamath S, Blann AD, Lip GY (2001) Platelet activation: assessment and quantification. Eur Heart J 22(17): 1561-71.
11. Monroe DM, Hoffman M, Oliver JA, Roberts HR (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99(3): 542-7.
12. Skarja GA, Brash JL (1997) Physicochemical properties and platelet interactions of segmented polyurethanes containing sulfonate groups in the hard segment. J Biomed Mater Res 34(4): 439-55.
13. Elwing H (1998) Protein absorption and ellipsometry in biomaterial research. Biomaterials 19(4-5): 397-406.
14. Thatte HS, Zagarins SE, Amiji M, Khuri SF (2004) Poly-N-acetyl glucosamine-mediated red blood cell interactions. J Trauma 57(1 Suppl): S7-12.
15. Kanko M, Liman T, Topcu S (2006) A low-cost and simple method to stop intraoperative leakage-type bleeding: use of the vancomycin-oxidized regenerated cellulose (ORC) sandwich. J Invest Surg 19(5): 323-7.
16. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A (2004) The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J 13(1): S89-96.
17. Palm MD, Altman JS (2008) Topical hemostatic agents: a review. Dermatol Surg 34(4): 431-45.
18. Hong YM, Loughlin KR (2006) The use of hemostatic agents and sealants in urology. J Urol 176(6 Pt 1): 2367-74.
19. Msezane LP, Katz MH, Gofrit ON, Shalhav AL, Zorn KC (2008) Hemostatic agents and instruments in laparoscopic renal surgery. J Endourol 22(3): 403-8.
20. Alexander JM, Rabinowitz JL (1978) Microfibrillar collagen (avitene) as a hemostatic agent in experimental oral wounds. J Oral Surg 36(3): 202-5.
21. Wagner WR, Pachence JM, Ristich J, Johnson PC (1996) Comparative in vitro analysis of topical hemostatic agents. J Surg Res 66(2): 100-8.
22. Jorgensen LN, Lind B, Hauch O, Leffers A, Albrecht-Beste E, Konradsen LA (1990) Thrombin-antithrombin III-complex & fibrin degradation products in plasma: surgery and postoperative deep venous thrombosis. Thromb Res 59(1): 69-76.
23. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB (1987) Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA 258(9): 1183-6.
24. Patrono C, Ciabattoni G, Pugliese F, Pierucci A, Blair IA, FitzGerald GA (1986) Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 77(2): 590-4.
25. Albrechtsen OK, Thaysen JH (1955) Fibrinolytic activity in human saliva. Acta Physiol Scand 35(2): 138-45.